This clinical trial tests if preoperative exercise programs, and if using an Apple Smart Watch for tracking exercise, may have an impact on level of physical activity, quality of life and return to baseline function after surgery in patients undergoing surgery for colorectal, hepatobiliary, or gynecologic cancer. An exercise program before surgery may help improve physical function before patients undergo surgery. Improving physical function before surgery may help improve quality of life, reduce recovery time, and shorten time to return to baseline function after surgery.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT04923672.
PRIMARY OBJECTIVE:
I. To estimate the potential impact of a prescribed, trackable preoperative exercise regimen on increasing pre-surgical physical activity as measured by steps per day.
SECONDARY OBJECTIVES:
I. To estimate the feasibility of using a wearable device to implement a preoperative exercise regimen in patients undergoing elective abdominal oncologic resection.
II. To estimate the potential impact of a prescribed, trackable, preoperative exercise regimen on postoperative patient reported outcomes and return to baseline quality of life.
III. To estimate the impact of a prescribed, trackable, preoperative exercise regimen on postoperative physical activity and fitness and return to baseline function.
EXPLORATORY OBJECTIVES:
I. To assess the patient perspective regarding self-efficacy, motivation, barriers and facilitators to completion of a prescribed, trackable, preoperative exercise regimen
II. To better understand the relationship between patients in this population and technology, including the smartphones and apps used in this study
III. To assess the feasibility of maximum oxygen uptake (VO2 max) testing as a measure of physical fitness in this patient population
IV. To estimate the potential impact of a prescribed, trackable, pre-operative exercise regimen on increasing pre-surgical physical fitness using the VO2max testing in a subset of participants
OUTLINE: Patients are randomized to 1 of 3 arms.
ARM A: Patients wear Apple Smart Watch until day of surgery and then for 30 days after surgery. Patients may optionally undergo collection of blood samples throughout the trial.
ARM B: Patients wear Apple Smart Watch until day of surgery and then for 30 days after surgery. Patients also undergo exercise regimen consisting of moderate continuous training over 40 minutes 5 days a week for at least 3 weeks before surgery. Patients may optionally undergo collection of blood samples throughout the trial.
ARM C: Patients wear Apple Smart Watch until day of surgery and then for 30 days after surgery. Patients also undergo exercise regimen consisting of high intensity interval training over 40 minutes 5 days a week for at least 3 weeks before surgery. Patients may optionally undergo collection of blood samples throughout the trial.
After completion of surgery, patients are followed up at 30, 90, and 180 days.
Trial PhaseNo phase specified
Trial Typesupportive care
Lead OrganizationUniversity of Virginia Cancer Center
Principal InvestigatorTraci Lynn Hedrick